GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » ROE % Adjusted to Book Value

Labiana Health (XMAD:LAB) ROE % Adjusted to Book Value : -39.39% (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health ROE % Adjusted to Book Value?

Labiana Health's ROE % for the quarter that ended in Dec. 2022 was -135.89%. Labiana Health's PB Ratio for the quarter that ended in Dec. 2022 was 3.45. Labiana Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 was -39.39%.


Labiana Health ROE % Adjusted to Book Value Historical Data

The historical data trend for Labiana Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health ROE % Adjusted to Book Value Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
- - -27.84

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
ROE % Adjusted to Book Value - - -9.45 -39.39

Competitive Comparison of Labiana Health's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Labiana Health's ROE % Adjusted to Book Value falls into.



Labiana Health ROE % Adjusted to Book Value Calculation

Labiana Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-96.04% / 3.45
=-27.84%

Labiana Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-135.89% / 3.45
=-39.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Labiana Health's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.